Current treatment for colorectal cancer metastatic to the liver

Research output: Contribution to journalReview articlepeer-review

63 Citations (Scopus)

Abstract

Surgery is currently the only available treatment option which offers the potential for cure for patients with liver metastases from colorectal cancer. Of those who undergo a potentially curative operation for their primary tumour but subsequently recur, almost 80% will develop evidence of metastatic disease within the liver. Greater experience and improvements in technique in liver surgery, with an increasingly aggressive surgical approach to metastatic colorectal cancer to the liver, has resulted in prolonged disease-free survival with 5-year rates varying from 21% to 48%. In order to increase these numbers further and to treat patients not eligible for surgical therapy, new treatment modalities and strategies have been developed. This review presents an update of the current treatment for colorectal disease metastatic to the liver.

Original languageEnglish
Pages (from-to)451-463
Number of pages13
JournalEuropean Journal of Surgical Oncology
Volume25
Issue number5
Publication statusPublished - Oct-1999

Keywords

  • colorectal cancer
  • liver metastasis
  • treatment
  • REPEAT HEPATIC RESECTION
  • PROSPECTIVE RANDOMIZED TRIAL
  • PHASE-I-II
  • PERIOPERATIVE BLOOD-TRANSFUSION
  • ARTERIAL INFUSION CHEMOTHERAPY
  • LASER-INDUCED THERMOTHERAPY
  • INTERNAL RADIATION-THERAPY
  • DISEASE-FREE SURVIVAL
  • LONG-TERM SURVIVAL
  • FOLLOW-UP

Fingerprint

Dive into the research topics of 'Current treatment for colorectal cancer metastatic to the liver'. Together they form a unique fingerprint.

Cite this